44
67
Growth Score
-8 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
97268
Astellas Pharma develops and commercializes prescription medicines across therapeutic areas.
Ana C. Ward: Vice President - Head of Affiliate EngagementPast Role: Asuragen, General Counsel & Senior Vice President- Atsushi Kamide: Corporate Executive
About the Company
Astellas Pharma develops and commercializes prescription medicines across therapeutic areas including oncology, ophthalmology, urology, immunology, and women’s health. The company conducts activities spanning drug discovery, clinical development, regulatory processes, and product distribution. It works with research partners to advance new
treatments and integrates scientific findings into its development pipeline. Its portfolio includes therapies designed to address specific medical conditions and support patient care. Astellas Pharma also applies data and digital approaches to support research and healthcare delivery processes.
